FDA 483 - EKF Diagnostics, Inc. dba EFK Life Sciences - November 09, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of EKF Diagnostics, Inc. dba EFK Life Sciences in Elkhart, IN, from November 7-9, 2022, identified significant deficiencies in the firm's control of nonconforming product. The inspection revealed inadequate procedures and documentation for rework activities, investigations into nonconformances, and the disposition of nonconforming products. These issues indicate a lack of robust quality system controls for managing products that do not meet specified requirements.
ID · fecf2d3f-e35c-4ada-941d-683e26e70692